Humana Inc. (NYSE:HUM) Shares Sold by Quantbot Technologies LP

Quantbot Technologies LP lessened its position in shares of Humana Inc. (NYSE:HUM) by 95.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,298 shares of the insurance provider’s stock after selling 30,286 shares during the quarter. Quantbot Technologies LP’s holdings in Humana were worth $329,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Pinnacle Wealth Management Advisory Group LLC lifted its holdings in shares of Humana by 3.6% in the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock valued at $272,000 after purchasing an additional 37 shares in the last quarter. Atlas Brown Inc. raised its position in shares of Humana by 0.6% in the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock valued at $1,611,000 after buying an additional 38 shares during the last quarter. Mather Group LLC. lifted its stake in shares of Humana by 21.0% during the fourth quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock valued at $60,000 after buying an additional 41 shares during the period. Capital Advisors Ltd. LLC boosted its position in Humana by 26.1% during the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider’s stock worth $53,000 after acquiring an additional 43 shares during the last quarter. Finally, Retirement Planning Co of New England Inc. grew its stake in Humana by 4.7% in the 4th quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider’s stock worth $245,000 after acquiring an additional 43 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.37% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Morgan Stanley decreased their price objective on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 12th. Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 price target on shares of Humana in a research note on Wednesday, February 12th. Barclays upped their price objective on shares of Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research note on Thursday, February 13th. JPMorgan Chase & Co. cut their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a report on Tuesday, February 18th. Finally, Truist Financial boosted their target price on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. Eighteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $285.68.

Humana Stock Performance

Humana stock opened at $263.95 on Friday. The firm has a market capitalization of $31.86 billion, a PE ratio of 26.53, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. The stock’s 50 day moving average price is $270.14 and its 200 day moving average price is $274.38. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a one year low of $213.31 and a one year high of $406.46.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, sell-side analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.34%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio (DPR) is currently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.